Latest News

Read the latest news from 23Strands, media releases, journal articles and company announcements.

Announcements Press Release

A New Chapter in Precision Medicine: Introducing Geneve Health Pty Ltd

23Strands News
23Strands News January 09, 2026

As 2026 begins, we're thrilled to announce the official launch of Geneve Health Pty Ltd (Geneve), a wholly 23Strands owned and dedicated entity, exclusively focused on advancing precision medicine in women's and reproductive health. This marks a pivotal moment in our mission to deliver healthcare as individually unique as each patient.

Geneve Health Pty Ltd
Geneve Health Pty Ltd
Redefining Women's Care Through Precision Medicine
For our partners and colleagues, this year promises especially meaningful progress. We're proud to announce the commercial launch of Geneve, our comprehensive women's and reproductive health program built on cutting-edge precision medicine, built on three foundational principles:

1. Personalised Genetic Insights
We're delivering advanced genomic analytics tailored specifically for fertility, pregnancy outcomes, and hormonal health. Our solutions go beyond basic carrier screening to provide actionable insights that guide individual care pathways.
2. AI-Powered Clinical Decision Support
Our proprietary algorithms analyse genetic data within the context of clinical history, family background, and environmental factors to generate predictive insights that inform treatment decisions.
3. Whole of-Life Care Continuum
We've designed a complete care experience spanning preconception planning, pregnancy management, reproductive lifecycle support and extending all the way to elderly care, each phase informed by
precision medicine data.
 
Our Philosophy: Care Built on Science, Guided by Compassion
At Geneve, we believe healthcare should move beyond one-size-fits-all approaches. Our philosophy is rooted in:
  • Individual biology over population averages - Treatment plans informed by a patient's unique genetic profile
  • Predictive insight over reactive care - AI-driven risk stratification that empowers proactive decision-making
  • Partnership over transaction - Collaborative care models that engage patients, clinicians, and families
The Geneve Health Platform: Built for Impact
Our 23Strands technology platforms combine to empower Geneve with:
  • Clinical-grade genetic testing with proprietary WGS bioinformatics and novel medical record analysis 
  • AI-powered analytics engines that translate data into clinical insights
  • Secure patient portal with family-sharing capabilities, educational resources and multi-disciplinary team based review
  • Practice tools for clinicians including interpretation guides, care pathways, and telehealth integration
Opportunities to Engage
As we roll out our services, we're pleased to extend early access to our valued network:

For Healthcare Providers
  • First look at clinical validation data
  • Training programs on genetic counselling and result interpretation
  • Practice implementation support and credentialing
For Payers & Employers
  • Customisable benefit packages tailored to precision medicine needs
  • Population health analytics dashboards
  • Care co-ordination tools
For Patients
  • Comprehensive genetic assessments with family planning specialists
  • Ongoing care management through our virtual clinic
  • Educational resources
Join Us in Transforming Women's Healthcare
We invite you to explore Geneve and learn how we're redefining what's possible in reproductive care. Our team is available for demonstrations, partnerships discussions, and collaborative innovation opportunities.

Visit geneve.health to discover our solutions and connect with the Geneve Health community.

As we welcome 2026, we're profoundly grateful for your continued partnership in advancing healthcare that works as uniquely as each person. This is just the beginning of what we'll achieve together.

The 23Strands & Geneve Health Team